Ocular Therapeutix Inc (NASDAQ: OCUL) stock closed at $4.04 on 12/19/23 after a major increase of 10.2%. Moreover, this advance was accompanied by exceptionally high trading volume at 223% of normal. The stock has been extremely weak relative to the market over the last nine months but has risen 17.1% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, OCUL is expected to continue to be a modest Value Eraser.
Ocular Therapeutix has a current Value Trend Rating of F (Lowest Rating). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Ocular Therapeutix has a very low Power Rating of 15 and a very low Appreciation Score of 3, leading to the Lowest Value Trend Rating.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment